By Salman Masood
“Access to the coronavirus vaccine has thrown a stark light on global inequality. The United States and other rich countries have bought up most of the world’s vaccine supplies to protect their own people, leaving millions of doses stockpiled and in some places unused. Less developed countries scramble over what’s left.
To speed up vaccinations, some countries have allowed doses to be sold privately. But those campaigns have been troubled by supply issues and by complaints that they simply reflect the global disparities.
‘The Pakistani example is a microcosm of what has gone wrong with the global response — where wealth alone has primarily shaped who gets access,’ Zain Rizvi, an expert on medicine access at Public Citizen, a Washington, D.C., advocacy group, said in an email. ‘Ending the pandemic will require the global community to do much more than just that.’”